Select the best management options for a type 2 diabetes patient on insulin therapy in this case study quiz.
Recently published consensus statement: Practical guidance for the use of IDegAsp in type 2 diabetes
Dr Sarah Glastras provides practical advice on the usage of the insulin degludec/insulin aspart coformulation, and outlines its role in insulin initiation and intensification in light of the recently released consensus statement.
Decide on the best course of action for a patient at risk of diabetes-related retinopathy in this case study quiz.
This guide summarises key information about DR in patients with type 2 diabetes and the GP’s role in screening, management and referral.
Dr Michelle Kiley outlines the aetiology and classification of status epilepticus, a condition involving abnormally prolonged seizues, and provides guidance on its identification, possible complications and management.
This module looks at the common causes of under-diagnosis and misdiagnosis of hereditary haemochromatosis in Australia. Participants will learn how to determine when hereditary haemochromatosis should be part of their differential diagnosis. The module also covers iron study test results and how to explain these results to patients.
This module provides an overview of hereditary haemochromatosis and the symptoms of iron overload. Participants will gain an understanding of how to interpret iron study results, and how to determine when genetic testing is warranted. The module also covers how to access the therapeutic venesection service offered by the Australian Red Cross Blood Service.
In this module, participants will learn about appropriate induction and maintenance venesection schedules for patients with hereditary haemochromatosis, as well as circumstances that warrant referral to a specialist. Participants will also learn how to access the Australian Red Cross Blood Service (ARCBS) High Ferritin app, and how to use it to screen patients for their eligibility to access therapeutic venesection. The module also looks at how to access local alternatives to the ARCBS therapeutic venesection service.